Table.
Study | Anabolic agent | Route | Injection site | Rhabdomyolysis | Patient features |
---|---|---|---|---|---|
Hageloch et al2 | Not reported | IM | Not reported | Diffuse | 31-y-old man, professional bodybuilder |
Adamson et al3 | Stanozolol plus metenolone | IM | Thigh | Diffuse | 25-y-old man, professional dancer |
Braseth et al4 | Not reported | Oral | N/A | Diffuse | 25-y-old man, amateur bodybuilder |
Gnanapandithan et al5 | Trenbolone | IM | Not reported | Diffuse | Young adult man |
Hughes and Ahmed6 | Not reported | IM | Not reported | Diffuse | 23-y-old man, recreational user, died from complications |
Farkash et al7 | Stanozolol | IM | Right deltoid | Deltoid/right upper extremity | 39-y-old man, amateur bodybuilder |
Daniels et al8 | Methyltestosterone Boldenone plus trenbolone |
Oral IM |
Thigh | Diffuse | 34-y-old man, amateur bodybuilder |
Abbreviations: IM = intramuscular; N/A = not applicable.